Deep Venous Arterialization: Indications, Technique, and Data
Presenter:
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Bard Medical; Terumo Medical Corporation; Medtronic; Abbott; Boston Scientific Corporation; Philips; W.L. Gore & Associates
- Equity/Stock(s)/Options - 2MG; Cardioflow; Vantis
- Research - Boston Scientific Corporation; CardioFlow; Micromedical Solutions; Reflow Medical
- Royalty/Intellectual Property Rights - Reflow Medical
Video Player is loading.